Earnings
BLRX
2.760
-3.50%
-0.100
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
16.83M
5.76M
--
--
--
--
141.00K
--
--
--
152.00K
--
22.88M
2.70M
--
--
--
--
21.71M
--
--
24.41M
47.29M
--
5.92M
0.00
--
--
--
1.44M
--
--
--
--
--
--
10.64M
4.40M
--
--
--
10.22M
14.62M
25.26M
9.87M
279.24M
-265.67M
--
--
--
22.03M
22.03M
47.29M
FY 2019-12-31
5.30M
22.19M
--
--
--
--
613.00K
--
--
--
108.00K
--
28.21M
3.47M
--
--
--
--
21.89M
--
0.00
25.36M
53.57M
--
7.79M
0.00
--
--
--
1.28M
--
--
--
--
--
--
11.97M
7.56M
--
--
--
658.00K
8.22M
20.19M
4.69M
265.94M
-235.83M
--
--
--
33.38M
33.38M
53.57M
FY 2018-12-31
2.33M
27.82M
--
--
--
--
1.34M
--
--
--
488.00K
--
31.98M
2.23M
--
0.00
--
--
21.97M
--
56.00K
24.25M
56.23M
--
4.49M
0.00
--
--
--
1.36M
--
1.35M
--
--
--
14.00K
6.75M
7.84M
--
--
--
323.00K
8.16M
14.91M
3.11M
250.19M
-210.56M
--
--
--
41.32M
41.32M
56.23M
FY 2017-12-31
3.96M
45.52M
--
--
--
--
586.00K
--
--
--
307.00K
--
50.38M
2.50M
--
1.00M
--
--
7.02M
--
61.00K
10.59M
60.97M
--
5.52M
0.00
--
--
--
--
--
1.09M
--
--
--
19.00K
6.72M
157.00K
--
--
--
1.21M
1.36M
8.08M
2.84M
240.68M
-189.22M
--
--
--
52.88M
52.88M
60.97M
FY 2016-12-31
969.00K
34.65M
--
--
--
--
223.00K
--
--
--
255.00K
--
36.10M
2.60M
--
0.00
--
--
181.00K
--
52.00K
2.84M
38.94M
--
2.59M
0.00
--
--
--
--
--
963.00K
--
--
--
15.00K
3.66M
250.00K
--
--
--
1000.00
251.00K
3.91M
1.51M
199.57M
-164.64M
--
--
--
35.03M
35.03M
38.94M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out BLRX latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze BioLine RX recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.